Strength
39150; 10440; 39150 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Aimmune Therapeutics, Inc.NDC
73562010410
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
12/31/2025
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022542On Market Since
3/1/2021
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
No related drugs found.